• レポートコード:MRC2105A019 • 出版社/出版日:Persistence Market Research / 2021年2月 • レポート形態:英文、PDF、260ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Site Licence | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Enterprisewide | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界のフェニルケトン尿症治療市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、市場分析/予測、価格分析、PKU成分別(グリコマクロペプチド(GMP)、必須・非必須アミノ酸)分析、ターゲット顧客別(大人、小児、妊婦)分析、形状別(粉末ブレンド、顆粒、タブレット、カプセル、パウダーサシェ、その他)分析、流通チャンネル別(病院薬局、小売薬局、オンライン薬局、ハイパーマーケット・スーパーマーケット)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・市場分析/予測 ・価格分析 ・世界のフェニルケトン尿症治療市場規模:PKU成分別(グリコマクロペプチド(GMP)、必須・非必須アミノ酸) ・世界のフェニルケトン尿症治療市場規模:ターゲット顧客別(大人、小児、妊婦) ・世界のフェニルケトン尿症治療市場規模:形状別(粉末ブレンド、顆粒、タブレット、カプセル、パウダーサシェ、その他) ・世界のフェニルケトン尿症治療市場規模:流通チャンネル別(病院薬局、小売薬局、オンライン薬局、ハイパーマーケット・スーパーマーケット) ・世界のフェニルケトン尿症治療市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Phenylketonuria Treatment Market- Scope of Report
A latest publication by Persistence Market Research on the global phenylketonuria treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for successful growth of the phenylketonuria treatment market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research’s study. This research study can support readers to know the demand for phenylketonuria treatment and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the phenylketonuria treatment landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the phenylketonuria treatment market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the phenylketonuria treatment industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the phenylketonuria treatment market offers information divided into five important segments — PKU ingredient, targeted customer, form, sales channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
PKU Ingredient
Protein Ingredients
Glycomacropeptide (GMP)
Essential and Non-essential Amino Acids
Finish Products
Glycomacropeptide (GMP)
Essential and non-essential amino acids
Targeted Customer
Protein Ingredients
Consumer Healthcare Companies
Pharmaceutical Companies
Contract Manufacturing Companies (CMOs)
Finish Products
Paediatrics
Adults
Pregnant Women
Form
Protein Ingredient
Powder Blend
Granules
Finish Products
Powder & Granules
Tablets
Capsules
Powder Sachets
Ready-to-Drink
Shakes
Others
Sales Channel
Protein Ingredients
Industry Sales (Ingredients)
Finish Products
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hypermarkets & Supermarkets
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA
Key Questions Answered in Report
Which geographic regions will continue to remain the most profitable markets for phenylketonuria treatment?
How will changing trends impact the market?
How will the COVID-19 pandemic impact market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the winning strategies of stakeholders in the phenylketonuria treatment market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can businesses in the phenylketonuria treatment market avail the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the phenylketonuria treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of phenylketonuria treatment market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the phenylketonuria treatment market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Products Adoption / Usage Analysis
4.2. Key Product USP/Details Analysis by Players
4.3. Promotional Strategies by Key Players
4.4. Key Industry Deals
4.5. PKU Ingredient Manufacturers/Suppliers
4.6. Key Regulations
4.7. Reimbursement Scenario
4.8. Epidemiology of Phenylketonuria, Key Countries
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Market Outlook
5.1.3. Global Phenylketonuria Treatment Market Outlook
5.1.4. Income Per Capita Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Rising Prevalence of Phenylketonuria
5.2.2. Rise in Health Concern
5.2.3. Increase in R&D funding for Phenylketonuria Treatment
5.2.4. Regulatory Dynamics
5.2.5. Cost of Medical Food Treatment
5.3. Value Chain Analysis
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By PKU Ingredient
6.4.2. Revenue By Targeted Customer
6.4.3. Revenue By Form
6.4.4. Revenue By Sales Channel
6.4.5. Revenue By Country
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Phenylketonuria Treatment Market, Protein Ingredient Production Volume (Tons per annum, TPA) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Protein Ingredient Production Volume (TPA) Analysis, 2015-2019
7.2. Current and Future Market Protein Ingredient Production Volume (TPA) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute Units Opportunity Analysis
8. Global Phenylketonuria Treatment Market – Retail Pricing Analysis
8.1. Regional Retail Pricing Analysis, By Product
8.2. Global Average Retail Pricing Analysis Benchmark
9. Global Phenylketonuria Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
9.1. Protein Ingredients
9.1.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
9.1.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
9.1.2.1. Y-o-Y Growth Trend Analysis
9.1.2.2. Absolute $ Opportunity Analysis
9.2. Final Products
9.2.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
9.2.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
9.2.2.1. Y-o-Y Growth Trend Analysis
9.2.2.2. Absolute $ Opportunity Analysis
10. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By PKU Ingredient
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By PKU Ingredient , 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By PKU Ingredient , 2020-2030
10.3.1. Protein Ingredients
10.3.1.1. Glycomacropeptide (GMP)
10.3.1.2. Essential and non-essential amino acids
10.3.2. Finish Products
10.3.2.1. Glycomacropeptide (GMP)
10.3.2.2. Essential and non-essential amino acids
10.4. Market Attractiveness Analysis By PKU Ingredient
11. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Targeted Customer
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Targeted Customer, 2015-2019
11.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Targeted Customer, 2020-2030
11.3.1. Protein Ingredients
11.3.1.1. Consumer Healthcare Companies
11.3.1.2. Pharmaceutical Companies
11.3.1.3. Contract Manufacturing Companies (CMOs)
11.3.2. Finish Products
11.3.2.1. Adults
11.3.2.2. Pediatrics
11.3.2.3. Pregnant Women
11.4. Market Attractiveness Analysis By Targeted Customer
12. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Form
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) By Form, 2015-2019
12.3. Current and Future Market Size (US$ Mn) and Forecast By Form, 2020-2030
12.3.1. Protein Ingredients
12.3.1.1. Powder Blend
12.3.1.2. Granules
12.3.2. Finish Products
12.3.2.1. Powder & Granules
12.3.2.2. Tablets
12.3.2.3. Capsules
12.3.2.4. Powder Sachets
12.3.2.5. Ready-to-Drink
12.3.2.6. Shake
12.3.2.7. Others
12.4. Market Attractiveness Analysis By Form
13. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Sales Channel
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) By Sales Channel, 2015-2019
13.3. Current and Future Market Size (US$ Mn) and Forecast By Sales Channel, 2020-2030
13.3.1. Protein Ingredients
13.3.1.1. Industry Sales (Ingredients)
13.3.2. Finish Products
13.3.2.1. Hospital Pharmacies
13.3.2.2. Retail Pharmacies
13.3.2.3. Online Pharmacies
13.3.2.4. Hypermarkets & Supermarkets
13.4. Market Attractiveness Analysis By Sales Channel
14. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019
14.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
15.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By PKU Ingredient
15.3.3. By Targeted Customer
15.3.4. By Form
15.3.5. By Sales Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. Latin America Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
16.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By PKU Ingredient
16.3.3. By Targeted Customer
16.3.4. By Form
16.3.5. By Sales Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Europe Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
17.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By PKU Ingredient
17.3.3. By Targeted Customer
17.3.4. By Form
17.3.5. By Sales Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. South Asia Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
18.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Thailand
18.3.1.3. Indonesia
18.3.1.4. Malaysia
18.3.1.5. Rest of South Asia
18.3.2. By PKU Ingredient
18.3.3. By Targeted Customer
18.3.4. By Form
18.3.5. By Sales Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. East Asia Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
19.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.1. By PKU Ingredient
19.3.2. By Targeted Customer
19.3.3. By Form
19.3.4. By Sales Channel
19.4. Market Attractiveness Analysis
19.5. Key Market Participants – Intensity Mapping
19.6. Drivers and Restraints – Impact Analysis
20. Oceania Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
20.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By PKU Ingredient
20.3.3. By Targeted Customer
20.3.4. By Form
20.3.5. By Sales Channel
20.4. Market Attractiveness Analysis
20.5. Key Market Participants – Intensity Mapping
20.6. Drivers and Restraints – Impact Analysis
21. Middle East and Africa Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
21.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. South Africa
21.3.1.4. Rest of Middle East and Africa
21.3.2. By PKU Ingredient
21.3.3. By Targeted Customer
21.3.4. By Form
21.3.5. By Sales Channel
21.4. Market Attractiveness Analysis
21.5. Key Market Participants – Intensity Mapping
21.6. Drivers and Restraints – Impact Analysis
22. Key and Emerging Countries Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030
22.1. Introduction
22.1.1. Market Value Proportion Analysis, By Key Countries
22.1.2. Global Vs. Country Growth Comparison
22.2. U.S. Phenylketonuria Treatment Market Analysis
22.2.1. By PKU Ingredient
22.2.2. By Targeted Customer
22.2.3. By Form
22.2.4. By Sales Channel
22.3. Canada Phenylketonuria Treatment Market Analysis
22.3.1. By PKU Ingredient
22.3.2. By Targeted Customer
22.3.3. By Form
22.3.4. By Sales Channel
22.4. Mexico Phenylketonuria Treatment Market Analysis
22.4.1. By PKU Ingredient
22.4.2. By Targeted Customer
22.4.3. By Form
22.4.4. By Sales Channel
22.5. Brazil Phenylketonuria Treatment Market Analysis
22.5.1. By PKU Ingredient
22.5.2. By Targeted Customer
22.5.3. By Form
22.5.4. By Sales Channel
22.6. U.K. Phenylketonuria Treatment Market Analysis
22.6.1. By PKU Ingredient
22.6.2. By Targeted Customer
22.6.3. By Form
22.6.4. By Sales Channel
22.7. Germany Phenylketonuria Treatment Market Analysis
22.7.1. By PKU Ingredient
22.7.2. By Targeted Customer
22.7.3. By Form
22.7.4. By Sales Channel
22.8. France Phenylketonuria Treatment Market Analysis
22.8.1. By PKU Ingredient
22.8.2. By Targeted Customer
22.8.3. By Form
22.8.4. By Sales Channel
22.9. Italy Phenylketonuria Treatment Market Analysis
22.9.1. By PKU Ingredient
22.9.2. By Targeted Customer
22.9.3. By Form
22.9.4. By Sales Channel
22.10. Spain Phenylketonuria Treatment Market Analysis
22.10.1. By PKU Ingredient
22.10.2. By Targeted Customer
22.10.3. By Form
22.10.4. By Sales Channel
22.11. BENELUX Phenylketonuria Treatment Market Analysis
22.11.1. By PKU Ingredient
22.11.2. By Targeted Customer
22.11.3. By Form
22.11.4. By Sales Channel
22.12. Russia Phenylketonuria Treatment Market Analysis
22.12.1. By PKU Ingredient
22.12.2. By Targeted Customer
22.12.3. By Form
22.12.4. By Sales Channel
22.13. China Phenylketonuria Treatment Market Analysis
22.13.1. By PKU Ingredient
22.13.2. By Targeted Customer
22.13.3. By Form
22.13.4. By Sales Channel
22.14. Japan Phenylketonuria Treatment Market Analysis
22.14.1. By PKU Ingredient
22.14.2. By Targeted Customer
22.14.3. By Form
22.14.4. By Sales Channel
22.15. South Korea Phenylketonuria Treatment Market Analysis
22.15.1. By PKU Ingredient
22.15.2. By Targeted Customer
22.15.3. By Form
22.15.4. By Sales Channel
22.16. India Phenylketonuria Treatment Market Analysis
22.16.1. By PKU Ingredient
22.16.2. By Targeted Customer
22.16.3. By Form
22.16.4. By Sales Channel
22.17. ASEAN Phenylketonuria Treatment Market Analysis
22.17.1. By PKU Ingredient
22.17.2. By Targeted Customer
22.17.3. By Form
22.17.4. By Sales Channel
22.18. Australia Phenylketonuria Treatment Market Analysis
22.18.1. By PKU Ingredient
22.18.2. By Targeted Customer
22.18.3. By Form
22.18.4. By Sales Channel
22.19. New Zealand Phenylketonuria Treatment Market Analysis
22.19.1. By PKU Ingredient
22.19.2. By Targeted Customer
22.19.3. By Form
22.19.4. By Sales Channel
22.20. GCC Countries Phenylketonuria Treatment Market Analysis
22.20.1. By PKU Ingredient
22.20.2. By Targeted Customer
22.20.3. By Form
22.20.4. By Sales Channel
22.21. Turkey Phenylketonuria Treatment Market Analysis
22.21.1. By PKU Ingredient
22.21.2. By Targeted Customer
22.21.3. By Form
22.21.4. By Sales Channel
22.22. South Africa Phenylketonuria Treatment Market Analysis
22.22.1. By PKU Ingredient
22.22.2. By Targeted Customer
22.22.3. By Form
22.22.4. By Sales Channel
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Concentration
23.3. Market Share Analysis of Top Players
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive (Tentative)
24.3.1. Protein ingredient manufacturers
24.3.1.1. Arla Foods Ingredients Group P/S
24.3.1.1.1. Overview
24.3.1.1.2. PKU Product Portfolio Analysis
24.3.1.1.3. Sales Footprint
24.3.1.1.4. Analyst Commentary
24.3.1.1.5. Strategy Overview
24.3.1.2. Archer Daniels Midland Company
24.3.1.2.1. Overview
24.3.1.2.2. PKU Product Portfolio Analysis
24.3.1.2.3. Sales Footprint
24.3.1.2.4. Analyst Commentary
24.3.1.2.5. Strategy Overview
24.3.1.3. BASF SE
24.3.1.3.1. Overview
24.3.1.3.2. PKU Product Portfolio Analysis
24.3.1.3.3. Sales Footprint
24.3.1.3.4. Analyst Commentary
24.3.1.3.5. Strategy Overview
24.3.1.4. Chr. Hansen
24.3.1.4.1. Overview
24.3.1.4.2. PKU Product Portfolio Analysis
24.3.1.4.3. Sales Footprint
24.3.1.4.4. Analyst Commentary
24.3.1.4.5. Strategy Overview
24.3.1.5. Cargill, Incorporated
24.3.1.5.1. Overview
24.3.1.5.2. PKU Product Portfolio Analysis
24.3.1.5.3. Sales Footprint
24.3.1.5.4. Analyst Commentary
24.3.1.5.5. Strategy Overview
24.3.1.6. Seidler Chemical Co, Inc.
24.3.1.6.1. Overview
24.3.1.6.2. PKU Product Portfolio Analysis
24.3.1.6.3. Sales Footprint
24.3.1.6.4. Analyst Commentary
24.3.1.6.5. Strategy Overview
24.3.2. Final product manufacturers
24.3.2.1. Nestlé S.A. (Vitaflo International)
24.3.2.1.1. Overview
24.3.2.1.2. PKU Product Portfolio Analysis
24.3.2.1.3. Sales Footprint
24.3.2.1.4. Analyst Commentary
24.3.2.1.5. Strategy Overview
24.3.2.2. Reckitt Benckiser Group plc. (Mead Johnson & Company, LLC.)
24.3.2.2.1. Overview
24.3.2.2.2. PKU Product Portfolio Analysis
24.3.2.2.3. Sales Footprint
24.3.2.2.4. Analyst Commentary
24.3.2.2.5. Strategy Overview
24.3.2.3. Abbott Laboratories
24.3.2.3.1. Overview
24.3.2.3.2. PKU Product Portfolio Analysis
24.3.2.3.3. Sales Footprint
24.3.2.3.4. Analyst Commentary
24.3.2.3.5. Strategy Overview
24.3.2.4. APR Applied Pharma Research S. A.
24.3.2.4.1. Overview
24.3.2.4.2. PKU Product Portfolio Analysis
24.3.2.4.3. Sales Footprint
24.3.2.4.4. Analyst Commentary
24.3.2.4.5. Strategy Overview
24.3.2.5. Ajinomoto Co., Inc.
24.3.2.5.1. Overview
24.3.2.5.2. PKU Product Portfolio Analysis
24.3.2.5.3. Sales Footprint
24.3.2.5.4. Analyst Commentary
24.3.2.5.5. Strategy Overview
24.3.2.6. VitafriendsPKU
24.3.2.6.1. Overview
24.3.2.6.2. PKU Product Portfolio Analysis
24.3.2.6.3. Sales Footprint
24.3.2.6.4. Analyst Commentary
24.3.2.6.5. Strategy Overview
24.3.2.7. Pristine Organics Pvt. Ltd
24.3.2.7.1. Overview
24.3.2.7.2. PKU Product Portfolio Analysis
24.3.2.7.3. Sales Footprint
24.3.2.7.4. Analyst Commentary
24.3.2.7.5. Strategy Overview
25. Assumptions and Acronyms Used
26. Research Methodology
Table 01: Global Phenylketonuria Treatment Market Volume (Tons per annum, TPA) Analysis and Opportunity Assessment 2015–2030, By PKU IngredientsTable 02: Global Phenylketonuria Treatment Market [Protein Ingredients] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 03: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 04: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 05: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 06: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 07: Global Phenylketonuria Treatment Market Value [Finish Products] (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 08: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 09: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 10: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 11: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 12: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 13: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 14: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 15: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030 2015–2030, By Form
Table 16: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 17: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 18: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 19: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 20: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030 2015–2030, By Form
Table 21: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 22: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 23: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 24: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 25: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 26: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 27: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 28: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 29: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 30: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015–2030, By Form
Table 31: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 32: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 33: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 34: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 35: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 36: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 37: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 38: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 39: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 40: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015–2030, By Form
Table 41: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 42: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 43: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 44: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 45: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 46: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 47: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 48: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 49: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 50: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015–2030, By Form
Table 51: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 52: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 53: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 54: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 55: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 56: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 57: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 58: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 59: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 60: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015–2030, By Form
Table 61: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 62: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 63: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 64: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 65: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 66: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 67: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 68: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 69: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 70: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015–2030, By Form
Table 71: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 72: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 73: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 74: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 75: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Form
Table 76: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel
Table 77: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 78: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By PKU Ingredients
Table 79: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Targeted Customer
Table 80: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015–2030, By Form
Table 81: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sales Channel